COMPOUND (INN): HOE490O - GLIMEPIRIDE / METFORMIN HCl (Amaryl® M)0 (Glimepiride/Metformin Hydrochloride Immediate Release Combination Tablet) in Fed Conditions in Healthy Male and/or Female Subjects.
Phase 1
Withdrawn
- Conditions
- Healthy
- First Posted Date
- 2015-03-23
- Last Posted Date
- 2020-09-18
- Lead Sponsor
- Pharmaceutical Research Unit, Jordan
- Registration Number
- NCT02395237
- Locations
- 🇯🇴
Arab Pharmaceutical industry Consulting/ Pharmaceutical Research Unit, Amman, Jordan
Semi-replicate Crossover Bioequivalence Study of Dirithromycin of (Abdi İbrahim İlaç San. Ve Tic. A. Ş., Turkey) in Healthy Subjects Under Fasting Conditions
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Drug: DYNABAC 250 MG ENTERIC COATED TABLETDrug: DIRITHROMYCIN 500 MG ENTERIC COATED TABLET
- First Posted Date
- 2014-09-11
- Last Posted Date
- 2020-09-18
- Lead Sponsor
- Pharmaceutical Research Unit, Jordan
- Target Recruit Count
- 48
- Registration Number
- NCT02237768
- Locations
- 🇯🇴
Arab Pharmaceutical industry Consulting/ Pharmaceutical Research Unit, Amman, Jordan
Semi-replicate Crossover Bioequivalence Study of Dirithromycin in Healthy Subjects Under Fed Conditions
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Drug: DYNABAC 250 MG ENTERIC COATED TABLETDrug: DIRITHROMYCIN 500 MG ENTERIC COATED TABLET
- First Posted Date
- 2014-09-11
- Last Posted Date
- 2020-09-18
- Lead Sponsor
- Pharmaceutical Research Unit, Jordan
- Target Recruit Count
- 48
- Registration Number
- NCT02237807
- Locations
- 🇯🇴
Arab Pharmaceutical industry Consulting/ Pharmaceutical Research Unit, Amman, Jordan
Bioequivalence Pilot Study of Dirithromycin of (Abdi İbrahim İlaç San.Ve.Tic.A.Ş,Turkey) in Healthy Subjects Under Fasting Condition
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Drug: DYNABAC 250 MG ENTERIC COATED TABLETDrug: DIRITHROMYCIN 500 MG ENTERIC COATED TABLET
- First Posted Date
- 2014-07-10
- Last Posted Date
- 2014-07-10
- Lead Sponsor
- Pharmaceutical Research Unit, Jordan
- Target Recruit Count
- 12
- Registration Number
- NCT02185833
- Locations
- 🇯🇴
Arab Pharmaceutical industry Consulting/ Pharmaceutical Research Unit, Amman, Jordan
Bioequivalence Pilot Study of Dirithromycin of (Abdi İbrahim İlaç San.Ve.Tic.A.Ş,Turkey) in Healthy Subjects Under Fed Condition
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Drug: DIRITHROMYCIN 500 MG ENTERIC COATED TABLETDrug: DYNABAC 250 MG ENTERIC COATED TABLET
- First Posted Date
- 2014-07-10
- Last Posted Date
- 2014-07-10
- Lead Sponsor
- Pharmaceutical Research Unit, Jordan
- Target Recruit Count
- 12
- Registration Number
- NCT02185846
- Locations
- 🇯🇴
Arab Pharmaceutical industry Consulting/ Pharmaceutical Research Unit, Amman, Jordan
Bioequivalence Study of FLURBIPROFEN 100 mg FAMOTIDINE 20 mg MULTI-LAYER TABLET in Healthy Subjects Under Fasting Conditions
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Drug: FLURBIPROFEN 100 mg FAMOTIDINE 20 mg MULTI-LAYER TABLETDrug: ANTADYS® 100 mg, PEPCID® 20 mg
- First Posted Date
- 2013-07-29
- Last Posted Date
- 2013-07-29
- Lead Sponsor
- Pharmaceutical Research Unit, Jordan
- Target Recruit Count
- 36
- Registration Number
- NCT01910090
- Locations
- 🇯🇴
Arab Pharmaceutical industry Consulting/ Pharmaceutical Research Unit, Amman, Jordan
Bioequivalence Study of Amlodipine / Losartan/ Hydrochlorothiazide of PHARMALINE, Lebanon Under Fastion Conditions
Phase 1
Completed
- Conditions
- Fasting
- Interventions
- Drug: Amlodipin, losartan, HCTZ
- First Posted Date
- 2012-10-25
- Last Posted Date
- 2013-07-25
- Lead Sponsor
- Pharmaceutical Research Unit, Jordan
- Target Recruit Count
- 39
- Registration Number
- NCT01713647
- Locations
- 🇯🇴
Pharmaceutical research unit, Amman, Jordan
© Copyright 2025. All Rights Reserved by MedPath